Literature DB >> 3153318

Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia).

R Habib1, J P Dommergues, M C Gubler, M Hadchouel, M Gautier, M Odievre, D Alagille.   

Abstract

Alagille syndrome is characterized by the association of chronic cholestasis with a paucity of interlobular bile ducts and a distinctive facies together with cardiovascular, skeletal and eye abnormalities. We examined the kidneys of 26 patients with this syndrome; 22 were under 3 years of age and 4 were 4, 6, 12 and 17 years old, respectively. Eighteen showed glomerular lesions of variable severity characterized by a mesangiolipidosis. In the 8 lesser affected patients light microscopy (LM) disclosed a fibrillar appearance of the mesangium, and electron microscopy (EM) showed lipid vacuoles widespread in the mesangial matrix. In the 10 patients who were affected to a greater degree LM and EM showed, in addition to the mesangial matrix changes, the presence of mesangial foam cells. Clinical signs of renal involvement were mild in all patients except for one who died from chronic renal failure at 8 months of age. The extent of mesangiolipidosis was not related to age but to the degree of cholestasis, the most severe lesions being observed in patients aged 3, 6, 8, and 14 months. The glomerular lesions observed in Alagille syndrome are strikingly similar to those observed in adults with lecithin-cholesterol acyl transferase deficiency and other conditions characterized by an increase in plasma lipoproteins rich in free cholesterol and in phospholipids. We conclude that glomerular involvement should be added to the characteristic features of Alagille syndrome. Also we found that the lipid deposition in the glomeruli of patients with Alagille syndrome is related to an abnormal lipid metabolism, which is the consequence of severe cholestasis. The most striking feature of our study is the early detection of the glomerular lesions, contrasting with the lack of overt clinical renal disease. Renal failure may be a major complication for patients with this syndrome in adulthood.

Entities:  

Mesh:

Year:  1987        PMID: 3153318     DOI: 10.1007/bf00849254

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  34 in total

1.  Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli.

Authors:  J M Amatruda; S Margolis; G M Hutchins
Journal:  Arch Pathol       Date:  1974-07

2.  Renal changes in experimental hypercholesterolemia in normal and in subdiabetic rabbits. I. Short term studies.

Authors:  K F Wellmann; B W Volk
Journal:  Lab Invest       Date:  1970-01       Impact factor: 5.662

3.  Foam cells in the renal glomerulus.

Authors:  I F McKenzie; P Kincaid-Smith
Journal:  J Pathol       Date:  1969-01       Impact factor: 7.996

4.  Hereditary cholestasis combined with peripheral pulmonary stenosis and other anomalies.

Authors:  N T Henriksen; F Langmark; S J Sorland; O Fausa; S Landaas; O Aagenaes
Journal:  Acta Paediatr Scand       Date:  1977-01

5.  Ocular findings in arteriohepatic dysplasia (Alagille's syndrome).

Authors:  K G Romanchuk; G F Judisch; D R LaBrecque
Journal:  Can J Ophthalmol       Date:  1981-04       Impact factor: 1.882

6.  Renal abnormalities in arteriohepatic dysplasia and nonsyndromic intrahepatic biliary hypoplasia.

Authors:  A E Oestreich; R J Sokol; F J Suchy; J E Heubi
Journal:  Ann Radiol (Paris)       Date:  1983 Feb-Mar

7.  Intrahepatic "cholestasis facies": is it specific for Alagille syndrome?

Authors:  R J Sokol; J E Heubi; W F Balistreri
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

8.  [Mesangial lipidosis associated with cholesterol polycoria].

Authors:  M Bürgin; U Neyer; G Kostner
Journal:  Nephrologie       Date:  1982

9.  Renal lipidosis associated with arteriohepatic dysplasia (Alagille's syndrome).

Authors:  M Chung-Park; M Petrelli; A S Tavill; P W Hall; M S Henoch; B B Dahms
Journal:  Clin Nephrol       Date:  1982-12       Impact factor: 0.975

10.  Arteriohepatic dysplasia: association of liver disease with pulmonary arterial stenosis as well as facial and skeletal abnormalities.

Authors:  S E Levin; P Zarvos; S Milner; A Schmaman
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

View more
  10 in total

Review 1.  Notch in the kidney: development and disease.

Authors:  Yasemin Sirin; Katalin Susztak
Journal:  J Pathol       Date:  2011-08-24       Impact factor: 7.996

2.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

3.  Renal anomalies in Alagille syndrome: a disease-defining feature.

Authors:  Binita M Kamath; Gisele Podkameni; Anne L Hutchinson; Laura D Leonard; Jennifer Gerfen; Ian D Krantz; David A Piccoli; Nancy B Spinner; Kathleen M Loomes; Kevin Meyers
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

4.  Oncogenic role of the Notch pathway in primary liver cancer.

Authors:  Jie Lu; Yujing Xia; Kan Chen; Yuanyuan Zheng; Jianrong Wang; Wenxia Lu; Qin Yin; Fan Wang; Yingqun Zhou; Chuanyong Guo
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

5.  Glomerular basement membrane lipidosis in Alagille syndrome.

Authors:  Jessica Davis; Ryan Griffiths; Kay Larkin; David Rozansky; Megan Troxell
Journal:  Pediatr Nephrol       Date:  2010-01-21       Impact factor: 3.714

6.  Ectopic notch activation in developing podocytes causes glomerulosclerosis.

Authors:  Aoife M Waters; Megan Y J Wu; Tuncer Onay; Jacob Scutaru; Ju Liu; Corrinne G Lobe; Susan E Quaggin; Tino D Piscione
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

7.  IgA nephritis in a patient with Alagille syndrome and a transplanted liver.

Authors:  N Gilboa; L Hopp; R M Agostini
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

Review 8.  Renal involvement and the role of Notch signalling in Alagille syndrome.

Authors:  Binita M Kamath; Nancy B Spinner; Norman D Rosenblum
Journal:  Nat Rev Nephrol       Date:  2013-06-11       Impact factor: 28.314

9.  Extreme Renal Pathology in Alagille Syndrome.

Authors:  Mei Lin Z Bissonnette; Jerome C Lane; Anthony Chang
Journal:  Kidney Int Rep       Date:  2016-11-09

10.  A two month male baby with Alagille Syndrome, posted for pyeloplasty: Anaesthesia management.

Authors:  T Deepa; Shwetha Gopalaiah; Prabha Parthasarathy; R Shreyavathi
Journal:  Indian J Anaesth       Date:  2020-07-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.